115
Participants
Start Date
June 24, 2021
Primary Completion Date
September 28, 2022
Study Completion Date
September 28, 2022
Durvalumab
Durvalumab
East Kent Hospital, Canterbury
Velindre Hospital, Cardiff
Harrogate and district NHS foundation Trust, Harrogate
Leeds Teaching Hospitals NHS Trust, Leeds
Guy's Hospital, London
The Royal Marsden NHS Foundation Trust, London
The Christie NHS Foundation, Manchester
Queen Alexandra Hospital, Portsmouth
Musgrove Park Hospital, Taunton
Royal Cornwall Hospitals NHS Trust, Truro
Lead Sponsor
AstraZeneca
INDUSTRY